Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 18 de mayo del 1998
Raloxifene is a novel selective estrogen receptor modulator that has estrogenic effects on bone and lipids, but estrogen antagonist effects on the breast and uterus. A new study indicates that Raloxifene, widely used for the treatment of osteoporosis, can substantially reduce the risk of breast cancer in postmenopausal women who are at normal risk for the disease, and may also decrease the risk of endometrial cancer. These findings follow the announcement of the results of a trial of tamoxifen, which found that the drug substantially reduced the risk of developing breast cancer in women at high risk of the disease, while slightly increasing the risk of other health problems, including blood clots and endometrial cancer.
A two-year study of 7,705 postmenopausal women up to 80 years (mean age 66.5 years) being treated for osteoporosis indicates that women at normal risk of developing breast cancer reduced their risk of developing the disease by approximately 66% with daily use of Raloxifene, compared to the control group. Early results also indicate no statistically significant increase in risk of endometrial cancer, a cancer of the lining of the uterus. It should be noted that these are relatively preliminary findings, and that longer-term studies will be needed to determine the full risks and benefits of the drug.
"Another weapon may be added to our arsenal of prevention with preliminary findings that raloxifene prevents breast cancer and may prevent endometrial cancer. Coming on the heels of the recent tamoxifen study, this is very exciting news," said Derrek Raghavan, MD, PhD, of the University of Southern California Norris Comprehensive Cancer Center. "However, these drugs are not for every woman. Before advocating their widespread use, further trials must be conducted to determine if these drugs actually prevent breast cancer, or merely delay it."
Endocrine System Cancers
Head and Neck Cancers
Urinary Tract Cancers
Bone Marrow Transplants
General Treatment Concerns
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
Cancer Resource List
Resources for Young Adults